Seeking Alpha

Vion Pharma (VION.OB)

()

Comments on VION.OB

  • This Week's Failed Trials, Missed Targets in Biotech [View article]
    Relating to, "A gel designed to prevent AIDS infections produced by Chadds Ford, Pennsylvania-based Endo Pharmaceuticals (ENDP) failed... More »
    Comment by Factation
    Dec 20 07:41 am |
    Rating: 0 0
  • Columbus Day Dash and Slash: DepoMed, Vivus, Oncolytics and RadNet [View article]
    The real questions on Vivus that need to be asked about Qnexa are as follows: 1. Why would a "Big Pharma" buy Vivus for Qnexa, a combo... More »
    Comment by PhillyDan
    Oct 13 13:46 pm |
    Rating: +1 -1
  • Extreme FDA Trades: 30 Stocks Under 5 Bucks [View article]
    Mike, Thanks for the article. What's your take on Neopharma (Neol.pk). I read on article on Biomedreports that there are many pending... More »
    Comment by sdmy123
    Oct 1 10:58 am |
    Rating: 0 0
  • Extreme FDA Trades: 30 Stocks Under 5 Bucks [View article]
    intranasal ketamine? really? Thanks for this info, this is interesting. I had no idea anyone was developing ketamine for this purpose. ... More »
    Comment by drbob66
    Sep 22 17:26 pm |
    Rating: 0 0
  • Pending FDA Decisions: 20 Extreme Trades [View article]
    Thanks mike, all your posts are big help, are you updating this list any time soon?, please let us know. Thanks again!
    Comment by santy
    Sep 12 09:20 am |
    Rating: 0 0
  • Vion Pharmaceuticals' Onrigin: Good Chance of FDA Approval [View article]
    I don't think Saito will want to think about vion for a long time. I also don't think someone needs to be a scientist to analyze a... More »
    Sep 2 09:24 am |
    Rating: 0 0
  • Vion Pharmaceuticals' Onrigin: Good Chance of FDA Approval [View article]
    Saito, did you watch the panel meeting? I take it no. It has nothing to do with the fda going against their guidance. One panelist asked... More »
    Sep 1 17:36 pm |
    Rating: 0 0
  • Vion Pharmaceuticals' Onrigin: Good Chance of FDA Approval [View article]
    What can I say. The FDA has once again gone completely against their own guidance in their recommendations against both Clolar and... More »
    Comment by R. Saito
    Sep 1 17:03 pm |
    Rating: 0 0
  • Vion Pharmaceuticals' Onrigin: Good Chance of FDA Approval [View article]
    Unanimous vote against approval. Awful call Saito and even reiterated after seeing the disastrous briefing documents. Hard to imagine... More »
    Sep 1 16:38 pm |
    Rating: +1 0
  • Vion Pharmaceuticals' Onrigin: Good Chance of FDA Approval [View article]
    Saito, i'm sorry, you seem sincere, but you are completely clueless. These were the ugliest briefing documents i've ever seen. Briefing... More »
    Sep 1 15:13 pm |
    Rating: 0 0
  • Vion Pharmaceuticals' Onrigin: Good Chance of FDA Approval [View article]
    Vion has a great new drug. I read in a financial magazine it could reach 10 dollars a share by the end of the year and as high as 25 in... More »
    Comment by 412295
    Sep 1 14:09 pm |
    Rating: 0 -1
  • Vion Pharmaceuticals' Onrigin: Good Chance of FDA Approval [View article]
    Thanks Mr. Saito...VION could not make it above $3.80 in the morning but its good too that its holding this range nicely...
    Comment by mshah
    Sep 1 12:20 pm |
    Rating: 0 -1
  • Vion Pharmaceuticals' Onrigin: Good Chance of FDA Approval [View article]
    Well, from here we have two important events, the ODAC meeting tomorrow and the actual FDA PDUFA decision date on December 12th. ... More »
    Comment by R. Saito
    Aug 31 17:21 pm |
    Rating: 0 -1
  • Vion Pharmaceuticals' Onrigin: Good Chance of FDA Approval [View article]
    Yes a great time to buy. There was just some profit taking by day traders. That's all. On Aug 28 10:24 AM nafizzle wrote: >... More »
    Comment by 412295
    Aug 31 15:22 pm |
    Rating: +1 -1
  • Vion Pharmaceuticals' Onrigin: Good Chance of FDA Approval [View article]
    Vion is a great company with a good future. I heard one analyst in a magazine article say that Vion could reach about 35 dollars a... More »
    Comment by 412295
    Aug 31 15:19 pm |
    Rating: +1 -1